MSB 3.21% $1.13 mesoblast limited

Ann: CEO Presentation to 2023 Annual General Meeting, page-21

  1. 15,643 Posts.
    lightbulb Created with Sketch. 5711
    The company had previously indicated that the FDA didn’t want the heart meeting while the GVHD application is ongoing.

    Can you advise when this comment was supposedly made by Mesoblast ? I don’t believe it to be true
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.